title: Clinical significance of immunogenicity in biologic therapy.
authors.affiliation: Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España. Electronic address: rriveradiaz@hotmail.com.
authors.forename: R
authors.initials: R
authors.lastname: Rivera
authors.affiliation: Servicio de Dermatología. Hospital Universitario La Paz, Madrid, España.
authors.forename: P
authors.initials: P
authors.lastname: Herranz
authors.affiliation: Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España.
authors.forename: F
authors.initials: F
authors.lastname: Vanaclocha
mesh_terms: D000465:Algorithms; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis / Q000097:blood / Q000276:immunology; D000917:Antibody Formation / Q000187:drug effects; D001691:Biological Therapy; D004351:Drug Resistance / Q000187:drug effects / Q000276:immunology; D057915:Drug Substitution; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007155:Immunologic Factors / Q000097:blood / Q000276:immunology* / Q000494:pharmacology / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007378:Interleukins / Q000037:antagonists & inhibitors; D017211:Treatment Failure; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000888:Antibodies, Anti-Idiotypic; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha